Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

EGF Ointment for Erlotinib Skin Lesion

This study has been completed.
Information provided by (Responsible Party):
Sung Yong Oh, Dong-A University Hospital Identifier:
First received: May 5, 2012
Last updated: November 2, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):